HK8091A - Iron complexes - Google Patents

Iron complexes Download PDF

Info

Publication number
HK8091A
HK8091A HK80/91A HK8091A HK8091A HK 8091 A HK8091 A HK 8091A HK 80/91 A HK80/91 A HK 80/91A HK 8091 A HK8091 A HK 8091A HK 8091 A HK8091 A HK 8091A
Authority
HK
Hong Kong
Prior art keywords
carbon atoms
hydrocarbon group
aliphatic
aliphatic hydrocarbon
hydroxy
Prior art date
Application number
HK80/91A
Other languages
English (en)
Inventor
Albert Callingham Brian
Charles Hider Robert
Kontoghiorghes George
Arthur Stockham Michael
Original Assignee
Btg International Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Btg International Limited filed Critical Btg International Limited
Publication of HK8091A publication Critical patent/HK8091A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/69Two or more oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/62Three oxygen atoms, e.g. ascorbic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40Oxygen atoms attached in positions 3 and 4, e.g. maltol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02Iron compounds
    • C07F15/025Iron compounds without a metal-carbon linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Conveying Record Carriers (AREA)
HK80/91A 1984-04-19 1991-01-24 Iron complexes HK8091A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848410289A GB8410289D0 (en) 1984-04-19 1984-04-19 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
HK8091A true HK8091A (en) 1991-02-01

Family

ID=10559910

Family Applications (1)

Application Number Title Priority Date Filing Date
HK80/91A HK8091A (en) 1984-04-19 1991-01-24 Iron complexes

Country Status (15)

Country Link
EP (1) EP0159194B1 (da)
JP (1) JPH0794467B2 (da)
AU (1) AU582153B2 (da)
CA (1) CA1286844C (da)
CY (1) CY1575A (da)
DE (1) DE3579730D1 (da)
DK (1) DK160986C (da)
GB (2) GB8410289D0 (da)
HK (1) HK8091A (da)
IE (1) IE58667B1 (da)
IL (1) IL74949A (da)
NZ (1) NZ211788A (da)
PH (1) PH25348A (da)
SG (1) SG92490G (da)
ZA (1) ZA852830B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8329043D0 (en) * 1983-10-31 1983-11-30 Hider R C Pharmaceutical compositions
CA1283404C (en) * 1986-07-01 1991-04-23 Shigeru Sanai Cephalosporin compounds, processes for their preparation and antibacterial agents
US4908371A (en) * 1987-11-10 1990-03-13 Ciba-Geigy Corporation Esterified hydroxy dihydropyridinones for treating diseases associated with trivalent metal ion overload
EP0325559B1 (de) * 1988-01-20 1993-12-15 Ciba-Geigy Ag Verfahren zur Herstellung von Komplexverbindungen
JPH03101676A (ja) * 1989-09-14 1991-04-26 Sansho Seiyaku Co Ltd 2―エトキシメチル―5―ヒドロキシ―γ―ピロン及び同化合物を有効成分とするメラニン生成抑制外用剤
AU7346091A (en) * 1990-03-02 1991-09-18 Byk Gulden Lomberg Chemische Fabrik Gmbh Preparations for mr diagnosis
EP0833627B1 (en) * 1995-06-10 2004-08-18 Vitra Pharmaceuticals Ltd. Iron compounds, compositions, methods of making the same and uses thereof
GB9621273D0 (en) 1996-10-11 1996-11-27 Cortecs Ltd Therapeutic method
ATE282411T1 (de) 2000-09-19 2004-12-15 Vitra Pharmaceuticals Ltd Eisenverbindungen
GB0211500D0 (en) 2002-05-18 2002-06-26 Vitra Pharmaceuticals Ltd Method of forming iron hydroxypyrone compounds
BR112012023780A2 (pt) 2010-03-23 2018-07-24 Vifor (International) Ag compostos complexos de ferro (iii) - b - cetoamida ou sais farmaceuticamente toleráveis desses, processo para a produção dos compostos complexos de ferro (iii), uso de compostos complexos de ferro (iii), fármaco contendo compostos complexos de ferro (iii) e composição contendo compostos complexos de ferro (iii)
GB201101370D0 (en) 2011-01-27 2011-03-09 Iron Therapeutics Holdings Ag Process
PE20141319A1 (es) 2011-03-29 2014-10-29 Vifor Int Ag Compuesto de complejos de fe(iii) para el tratamiento y profilaxis de sintomas de deficiencia de hierro y anemias por deficiencia de hierro
US20140248342A1 (en) 2011-05-31 2014-09-04 Vifor (International) Ag Fe(III) 2,4-Dioxo-1-Carbonyl Complexes For Treatment And Prophylaxis Of Iron Deficiency Symptoms And Iron Deficiency Anaemias
BR112015014917A2 (pt) 2012-12-21 2017-07-11 Vifor Int Ag uso de compostos de complexo de ferro(iii)-2-oxo-butanodiamida ou sais farmaceuticamente aceitáveis dos mesmos; medicamento; e uso de composições
US11155529B2 (en) * 2016-03-31 2021-10-26 Shield TX (UK) Limited Methods for producing ferric maltol compositions from elemental iron
CN109311837B (zh) * 2016-03-31 2022-09-30 英国神盾Tx股份有限公司 用于由氢氧化亚铁产生麦芽酚铁组合物的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2117766B (en) * 1982-03-24 1985-08-29 Nat Res Dev Pharmaceutical compositions
DK157856C (da) * 1982-03-24 1990-07-30 Nat Res Dev Analogifremgangsmaade til fremstilling af et 3:1 hydroxypyridon:jern (iii)-kompleks
EP0107458B1 (en) * 1982-10-22 1987-07-29 National Research Development Corporation Pharmaceutical compositions
GB8308055D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions

Also Published As

Publication number Publication date
IL74949A (en) 1988-05-31
EP0159194B1 (en) 1990-09-19
GB2157686A (en) 1985-10-30
EP0159194A3 (en) 1986-03-12
DK160986C (da) 1991-11-11
GB2157686B (en) 1987-12-16
GB8410289D0 (en) 1984-05-31
PH25348A (en) 1991-05-13
ZA852830B (en) 1986-12-30
DK175585A (da) 1985-10-20
DK175585D0 (da) 1985-04-18
IE850992L (en) 1985-10-19
JPS60248696A (ja) 1985-12-09
CY1575A (en) 1991-12-20
CA1286844C (en) 1991-07-23
NZ211788A (en) 1988-06-30
AU582153B2 (en) 1989-03-16
DK160986B (da) 1991-05-13
GB8509813D0 (en) 1985-05-22
SG92490G (en) 1991-02-14
JPH0794467B2 (ja) 1995-10-11
IE58667B1 (en) 1993-11-03
DE3579730D1 (de) 1990-10-25
EP0159194A2 (en) 1985-10-23
AU4141385A (en) 1985-10-24

Similar Documents

Publication Publication Date Title
IE842799L (en) Zinc containing composition
AU561599B2 (en) Nmr contrast agents
IL74950A (en) Pharmaceutical compositions comprising iron complexes with hydroxypyrone derivatives
DE3674515D1 (en) Carboxy, carbalkoxy und carbamyl substituierte isonitril-radionukleid-komplexe.
HK5190A (en) Iron complexes of 3-hydroxypyrid-2-and-4-ones
ES471440A1 (es) Procedimiento para preparar una composicion de polimero re- sinoso con elevada resistencia a los impactos
BG93995A (bg) Хелати и комплекси на антибиотици с бивалентни и/или тривалентни метали, метод за получаването им и използването им за получаване на противоязвени средства
AU582153B2 (en) Iron complexes
AU498822B2 (en) Metal laminates for video i' scs
AU497395B2 (en) Preheating and preparing ferrous metal for galvanising
AU498023B2 (en) Iron alloy plating
AU4004278A (en) Pyrimido (2,1-a) isoquinoline derivatives
AU1218988A (en) Polyalkylamine complexes for ligand extraction and generation
GB2055377B (en) Cis-platinum (11) amine ascorbate complexes
AU1581776A (en) Process for the decarbonization of high carbon ferro-manganese or of high carbon ferro-chrome
EP0290169A3 (en) Diamineplatinum complexes with phosphonocarboxylate and substituted phosphonocarboxylate ligands as antitumor agents
CA2046313A1 (en) Platinum (ii) complex and agent for treating malignant tumor
AU2755388A (en) Polymeric polyalcohols
JPS5669294A (en) Blended fertilizer manufacture utilizing iron slag
ES474175A1 (es) Un procedimiento para la preparacion de compuestos derivadosde acido bis-azidoftalico
ES488134A1 (es) Un procedimiento para la preparacion de derivados de 6,7- benzomorfan
SG15086G (en) Oximino-imino-isoindoline metal complexes useful as pigments
JPS5337645A (en) Iron complexes of bis (5,6-diaminocalicenes)
DK551383A (da) Farmaceutiske praeparater indeholdende jernkomplekser
DE3264330D1 (en) Process for the preparation of cycloalkenon derivatives

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)